Business Description
Eloxx Pharmaceuticals is a clinical-stage drug development company headquartered in Arlington, Massachusetts, with operations in Israel and Australia. The company focuses on treatments for rare genetic diseases caused by nonsense mutations ? errors in genetic code that cause the body to stop producing essential proteins too early. Its lead drug candidate, ezutromid, is being tested in clinical trials for rare kidney conditions, while a separate compound is being developed with partner Almirall S.A. to treat serious inherited skin disorders.
